Table: Kobayashi Pharmaceutical - 6-MTH group results
Aug 3 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2022 Jun 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 71.26 67.05 162.00
(+6.3 pct) (+1.3 pct) (+4.3 pct)
Operating 9.87 10.24 27.00
(-3.6 pct) (+0.2 pct) (+3.6 pct)
Recurring 10.90 11.09 28.20
(-1.7 pct) (+0.6 pct) (+0.7 pct)
Net 7.70 7.88 20.20
(-2.3 pct) (-4.1 pct) (+2.5 pct)
EPS 99.55 yen 100.84 yen 259.85 yen
Ann Div 83.00 yen 85.00 yen
-Q2 div 38.00 yen 37.00 yen
-Q4 div 46.00 yen 47.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows